Management & Regulatory

What Will Drive the Future of Nitinol Medical Devices?
Management & Regulatory What Will Drive the Future of Nitinol Medical Devices?

The realm of medical devices is on a transformative path, markedly influenced by the integration of advanced materials like Nitinol. Known for its remarkable superelasticity, shape memory effect, and superior damping characteristics, Nitinol stands as a cornerstone in the development of innovative

What Drives Growth in Global Medical Device Clinical Trials?
Management & Regulatory What Drives Growth in Global Medical Device Clinical Trials?

The global medical device clinical trials market is experiencing remarkable growth, with forecasts predicting an upward trajectory from USD 16.70 billion in 2024 to USD 30.53 billion by 2034. This substantial increase is largely driven by the pervasive rise in chronic diseases, which sets the stage

Navigating Medtech Challenges: Regulatory, Reshoring, and Tech Gaps
Management & Regulatory Navigating Medtech Challenges: Regulatory, Reshoring, and Tech Gaps

The medical and life sciences manufacturing sector is experiencing rapid transformations, bringing forth a plethora of challenges and opportunities for industry professionals. Ascential's "2025 State of Medical & Life Sciences Manufacturing" report delves into key areas such as

Will Mehmet Oz Revolutionize Telehealth with New CMS Policies?
Management & Regulatory Will Mehmet Oz Revolutionize Telehealth with New CMS Policies?

The rapid advancements in telehealth have been met with a mixture of enthusiasm and concern, especially as regulatory frameworks struggle to keep pace with technological innovations. At the center of this challenge is Mehmet Oz, the newly appointed Administrator of the Centers for Medicare

Novartis' Vanrafia Approved by FDA for Rare Kidney Disease Treatment
Management & Regulatory Novartis' Vanrafia Approved by FDA for Rare Kidney Disease Treatment

Ivan Kairatov is a recognized authority in the biopharma sector, with an extensive background in technological advancements and R&D. In this interview, Ivan shares his insights on the new FDA-approved treatment for IgA nephropathy (IgAN), shedding light on its significance in treating this rare

HHS Layoffs and Reorganization Spark Opposition and Legal Action
Management & Regulatory HHS Layoffs and Reorganization Spark Opposition and Legal Action

The U.S. Department of Health and Human Services (HHS) is experiencing a turbulent phase marked by extensive layoffs and a major reorganization under Secretary Robert F. Kennedy Jr. These moves have ignited substantial controversy and legal battles, drawing sharp reactions from various stakeholders

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later